跳至主要内容
临床试验/NCT07250100
NCT07250100招募中不适用

The Role of Microbiota in Pancreatic Cancer and Precursor Lesions

Herlev Hospital1 个研究点 分布在 1 个国家目标入组 300 人开始时间: 2025年11月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
300
试验地点
1
主要终点
Composition of microbiota in pancreatic cancer

研究概览

简要总结

This is a prospective observational study aiming to investigate the microbiome in patients suspected of having pancreatic cancer. The purpose is to enhance diagnostic accuracy by developing screening protocols for high-risk individuals, identifying specific microbial biomarkers, and improving prognostic criteria to optimize treatment response.

Participants will be asked to complete a questionnaire, provide oral and fecal swabs, and-if clinically indicated-1-2 pancreatic biopsies will be collected.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with a suspected lesion (solid/cystic) in the pancreas undergoing diagnostic or therapeutic endoscopic procedure
  • Age of 18 years or above
  • Signed informed consent form

排除标准

  • Contraindications for endoscopic or surgical procedure, such as uncorrected coagulopathy

结局指标

主要结局

Composition of microbiota in pancreatic cancer

时间窗: 2037

To examine the composition of microbiota in pancreatic cancer and its precursors, to explore association between bacterial/fungal genera and final diagnosis, survival and risk of recurrence, but also to examine a possible role of microbiota in development of surgical adverse events.

次要结局

  • Databank(2037)
  • Biobank(2037)
  • Intratumor and gut mikrobiota(2037)
  • Intratumor viral DNA(2037)
  • Microbiome-tumor interaction(2037)
  • Microbiome composition(2037)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Bojan Kovacevic

MD, ph.d.

Herlev Hospital

研究点 (1)

Loading locations...

相似试验